TRAF4 and TRAF6, noncanonical members of the TRAF family, are widely recognized as oncogenes in various human malignancies, including lung cancer, breast cancer, ovarian cancer, melanomas, neurogenic tumors, colon cancer, osteosarcoma, and pancreatic cancer [21–25]. Here, TRAF4 is linked to ovarian carcinoma.